Avid Bioservices Inc (CDMO)

[cjgaddy]

Nov16 2013: 1-day Symposium on Lung Cancer in Manhattan Beach, CA – now listed on Peregrine Events page ( http://ir.peregrineinc.com/events.cfm ). Can’t tell as yet Peregrine’s role at this. Could it be that PS-targeting (incl. Bavi) will be discussed by a new KOL beyond the 2 new ones introduced at IASLC/Sydney on 10-28-13? IE, Scott J. Antonia/MD-PhD(H.Lee Moffitt CC) & Dmitry I. Gabrilovich/MD-PhD(Wistar Inst)…

Nov16 2013: “6th Annual Symposium on Personalized Therapies & Best Clinical Practices for Lung Cancer”, Manhattan Beach, CA
Appears to be an educational initiative of IASLC…
IASLC = Intl. Association for the Study of Lung Cancer
”…Now in its SIXTH consecutive year it utilizes a highly interactive clinical case-study format in a 1-day meeting with a faculty of the top lung cancer experts to provide you with the most current information and data for use in your practice today. Each of the presentations includes patient case studies where you make treatment selections based upon real-life scenarios, using the hand-held audience response system. And back by popular demand is the "Lunch with the Professors" where you can sit with the faculty expert of your choice. This Sixth Annual Symposium contains the summary of what you need to know for improving the outcomes of your patients. It includes highlights of the biannual Intl. Symposium on Lung Cancer by the IASLC conducted in Oct. 2013 in Sydney, Australia, only 2 weeks before this symposium. We urge you to review the agenda, faculty and other highlights regarding this symposium reviewed on this Website to fully understand and appreciate all of what this symposium has to offer you for only a very modest tuition…”
…Symposium Co-chairs are Dr. Paul A. Bunn, Jr. and Dr. Roy S. Herbst
http://www.iaslc.org/events/6th-annual-symposium-personalized-therapies-and-best-clinical-practices-lung-cancer
More info: http://www.bmli.com/lungcancer/ (BMLI - “Case-based Learning”)
BMLI Conf. Home: http://www.bmli.com/lungcancer/
Agenda: http://www.bmli.com/lungcancer/agenda.php

= = = = = = = = = = = = = = = =
10-28-13 IASLC/Sydney: “Immune Checkpoints in the Tumor Environment: Novel Targets & the Clinical Promise of Combined Immunotherapies” http://tinyurl.com/mjaweu5
…Symposium speakers: Scott J. Antonia/MD-PhD(H.Lee Moffitt CC), Dmitry I. Gabrilovich/MD-PhD(Wistar Inst), Rolf A. Brekken/PhD(UTSW), David E. Gerber/MD(UTSW)